3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
3
Rectal Neoplasms
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Prostatic Neoplasms
1
Prostate Cancer, Hereditary, 7
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Muscle Weakness
1
Health Status Unknown
1
Glioma
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Colonic Neoplasms
1
Astrocytoma
1
Anus Neoplasms
1
Interventions
pembrolizumab
18
Specimen Handling
16
Magnetic Resonance Spectroscopy
11
Biopsy
11
Paclitaxel
8
Carboplatin
8
trastuzumab deruxtecan
6
Pemetrexed
6
Nivolumab
6
Irinotecan
6
Fulvestrant
6
Bevacizumab
6
Radiosurgery
5
Leucovorin
5
Gemcitabine
5
Fluorouracil
5
Cetuximab
5
palbociclib
4
Oxaliplatin
4
Letrozole
4
Cisplatin
4
olaparib
3
durvalumab
3
Taxes
3
Ipilimumab
3
Docetaxel
3
Capecitabine
3
130-nm albumin-bound paclitaxel
3
sacituzumab govitecan
2
ribociclib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Magnetic Resonance Imaging
×
30 days
×
Clear all
No trials found.